Back
Relay Therapeutics Stock Price Chart
"This Changes Everything" - Trump Hands Millions Massive IRS Gift
Learn More Here
Sell
18
RLAY
Relay Therapeutics
Last Price:
4.66
Seasonality Move:
-6.4%
7 Day Trial
ALL ACCESS PASS
$
7
Trump's IRS Hands Massive 'Victory Gift' To 401K Owners
Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RLAY is experiencing slight buying pressure.
Relay Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.37 | Sell |
| 20-day SMA: | 5.73 | Sell |
| 50-day SMA: | 6.5 | Sell |
| 200-day SMA: | 7.36 | Sell |
| 8-day EMA: | 5.22 | Sell |
| 20-day EMA: | 5.69 | Sell |
| 50-day EMA: | 6.26 | Sell |
| 200-day EMA: | 7.52 | Sell |
Relay Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.42 | Sell |
| Relative Strength Index (14 RSI): | 23.85 | Sell |
| Chaikin Money Flow: | 194739 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (5.35 - 6.45) | Sell |
| Bollinger Bands (100): | (5.96 - 8) | Sell |
Relay Therapeutics Technical Analysis
| Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Relay Therapeutics Stock
Is Relay Therapeutics Stock a Buy?
- Relay Therapeutics share price is 4.66 while RLAY 8-day simple moving average is 5.37, which is a Sell signal.
- The stock price of RLAY is 4.66 while Relay Therapeutics 20-day SMA is 5.73, which makes it a Sell.
- Relay Therapeutics 50-day simple moving average is 6.50 while RLAY share price is 4.66, making it a Sell technically.
- RLAY stock price is 4.66 and Relay Therapeutics 200-day simple moving average is 7.36, creating a Sell signal.
RLAY Technical Analysis vs Fundamental Analysis
Sell
18
Relay Therapeutics (RLAY)
is a Sell
Is Relay Therapeutics a Buy or a Sell?
-
Relay Therapeutics stock is rated a Sell
The current Relay Therapeutics [RLAY] share price is $4.66. The Score for RLAY is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
Relay Therapeutics Stock Info
Market Cap:
780M
Price in USD:
4.66
Share Volume:
2.92M
Relay Therapeutics 52-Week Range
52-Week High:
12.14
52-Week Low:
4.88
Sell
18
Relay Therapeutics (RLAY)
is a Sell
Relay Therapeutics Share Price Forecast
-
What is the Relay Therapeutics stock price today?
The Relay Therapeutics stock price is 4.66 USD today. -
Will RLAY stock go up or go down?
Relay Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Relay Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Relay Therapeutics is overvalued.
Is Relay Therapeutics Stock a Buy?
- Relay Therapeutics share price is 4.66 while RLAY 8-day exponential moving average is 5.22, which is a Sell signal.
- The stock price of RLAY is 4.66 while Relay Therapeutics 20-day EMA is 5.69, which makes it a Sell.
- Relay Therapeutics 50-day exponential moving average is 6.26 while RLAY share price is 4.66, making it a Sell technically.
- RLAY stock price is 4.66 and Relay Therapeutics 200-day simple moving average is 7.52, creating a Sell signal.
Fundamental Analysis of Relay Therapeutics
Is Relay Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.36 per share, and a decrease next year of $0.02 per share.
Technical Analysis of Relay Therapeutics
Should I short Relay Therapeutics stock?
- RLAY Moving Average Covergence Divergence (MACD) indicator is -0.42, suggesting Relay Therapeutics is a Sell
- Relay Therapeutics Relative Strength Index (RSI) is 23.85, which suggest Relay Therapeutics is oversold
- The Bollinger Bands (25) for Relay Therapeutics is (5.35 - 6.45), which suggest Relay Therapeutics is a Sell
- The Bollinger Bands (100) for Relay Therapeutics is (5.96 - 8), which suggest Relay Therapeutics is a Sell
* Relay Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.